Syntec Optics Holdings, Inc. (OPTX) has seen its shares soar by 316.4% year-to-date, significantly outpacing the technology services industry, which has grown by only 0.8%. The company has garnered over $4 million in defense orders amid rising demand for its optics used in military applications, including missile guidance and night-vision systems, as global defense spending increases. Syntec operates from a 90,000-square-foot facility in Rochester, NY, specializing in precision optics for sectors such as defense, biomedical, and communications.
Despite these successes, Syntec Optics reported an 8% decline in revenue year-over-year in Q1 2026, primarily due to lower sales in the medical market. Furthermore, the company’s gross profit fell 58%, reflecting increased material costs. Currently, OPTX trades at a trailing 12-month EV/sales value of 16.07, compared to 3.43 for the industry average, indicating a relatively high valuation despite operational challenges.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
